Proper detection of the nuclear shape: Ways and significance

Romanian Journal of Morphology and Embryology

Volumn 49, Issue 4, 2008, Pages 435-439

  Bussolati, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

3D; Breast cancer; Immunofluorescence; Nuclear envelope; Pleomorphism; Thyroid carcinoma

Indexed keywords

BREAST TUMOR; CARCINOMA; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CYTOLOGY; HUMAN; METHODOLOGY; NUCLEAR SHAPE; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; REVIEW; THREE DIMENSIONAL IMAGING; THYROID TUMOR; ULTRASTRUCTURE;

BREAST NEOPLASMS; CARCINOMA; CELL NUCLEUS; CELL NUCLEUS SHAPE; CYTOLOGICAL TECHNIQUES; HUMANS; IMAGING, THREE-DIMENSIONAL; NUCLEAR ENVELOPE; PROGNOSIS; THYROID NEOPLASMS;

EID: 70449931521     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. BRACEGIRDLE B., A history of microtechnique, Cornell University Press, Ithaca, NY, 1978.
2. GHADIALLY F. N., Ultrastructural pathology of the cell and matrix: a text and atlas of physiological and pathological alterations in the fine structure of cellular and extracellular components, vol. 1 and 2, 3rd edition, Butterworths, London-Wellington, 1988.
3. BOYD J., PIENTA K. J., GETZENBERG R. H., COFFEY D. S., BARRETT J. C., Preneoplastic alterations in nuclear morphology that accompany loss of tumor suppressor phenotype, J Natl Cancer Inst, 1991, 83(12):862-866.
4. FROST J. K., The cell in health and disease: an evaluation of cellular morphologic expression of biologic behavior, 2nd revised edition, Karger, Basel, 1986.
5. FISCHER A. H., BARDAROV S. JR., JIANG Z., Molecular aspects of diagnostic nucleolar and nuclear envelope changes in prostate cancer, J Cell Biochem, 2004, 91(1):170-184.
6. FISCHER A. H., TAYSAVANG P., JHIANG S. M., Nuclear envelope irregularity is induced by RET/PTC during interphase, Am J Pathol, 2003, 163(3):1091-1100.
7. ELSTON C. W., ELLIS I. O., Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up, Histopathology, 1991, 19(5):403-410.
8. VOLPI A., BACCI F., PARADISO A., SARAGONI L., SCARPI E., RICCI M., ALDI M., BIANCHI S., MURETTO P., NUZZO F., SIMONE G., MANGIA A., SCHITTULLI F., AMADORI D., Prognostic relevance of histological grade and its components in node-negative breast cancer patients, Mod Pathol, 2004, 17(9):1038-1044.
9. BROERS J. L., HUTCHISON C. J., RAMAEKERS F. C., Laminopathies, J Pathol, 2004, 204(4):478-488.
10. PEMBERTON L. F., PASCHAL B. M., Mechanisms of receptor-mediated nuclear import and nuclear export, Traffic, 2005, 6(3):187-198.
11. BECK M., LUCIĆ V., FÖRSTER F., BAUMEISTER W., MEDALIA O., Snapshots of nuclear pore complexes in action captured by cryo-electron tomography, Nature, 2007, 449(7162):611-615.
12. PAPOTTI M., MANAZZA A. D., CHIARLE R., BUSSOLATI G., Confocal microscope analysis and three-dimensional reconstruction of papillary thyroid carcinoma nuclei, Virchows Arch, 2004, 444(4):350-355.
13. HOLMES T. J., Blind deconvolution of quantum-limited incoherent imagery: maximum-likelihood approach, J Opt Soc Am A, 1992, 9(7):1052-1061.
14. HOLMES T. J., O'CONNOR N. J., Blind deconvolution of 3D transmitted light brightfield micrographs, J Microsc, 2000, 200(Pt 2):114-127.
15. MEYER J. S., ALVAREZ C., MILIKOWSKI C., OLSON N., RUSSO I., RUSSO J., GLASS A., ZEHNBAUER B. A., LISTER K., PARWARESCH R.; COOPERATIVE BREAST CANCER TISSUE RESOURCE. Breast carcinoma malignancy grading by Bloom-Richardson system vs. proliferation index: reproducibility of grade and advantages of proliferation index, Mod Pathol, 2005, 18(8):1067-1078
16. SLOANE J. P., AMENDOEIRA I., APOSTOLIKAS N., BELLOCQ J. P., BIANCHI S., BOECKER W., BUSSOLATI G., COLEMAN D., CONNOLLY C. E., EUSEBI V., DE MIGUEL C., DERVAN P., DRIJKONINGEN R., ELSTON C. W., FAVERLY D., GAD A., JACQUEMIER J., LACERDA M., MARTINEZ-PENUELA J., MUNT C., PETERSE J. L., RANK F., SYLVAN M., TSAKRAKLIDES V., ZAFRANI B., Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology, Virchows Arch, 1999, 434(1):3-10.
17. BAAK J. P., VAN DIEST P. J., VOORHORST F. J., VAN DER WALL E., BEEX L. V., VERMORKEN J. B., JANSSEN E. A., Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years, J Clin Oncol, 2005, 23(25):5993-6001.
18. KAU T. R., WAY J. C., SILVER P. A., Nuclear transport and cancer: from mechanism to intervention, Nat Rev Cancer, 2004, 4(2):106-117.
19. BUSSOLATI G., MARCHIÒ C., GAETANO L., LUPO R., SAPINO A., Pleomorphism of the nuclear envelope in breast cancer: a new approach to an old problem, J Cell Mol Med, 2008, 12(1):209-218.
20. GRAY A., DONIACH I., Morphology of the nuclei of papillary carcinoma of the thyroid, Br J Cancer, 1969, 23(1):49-51.
21. HAPKE M. R., DEHNER L. P., The optically clear nucleus. A reliable sign of papillary carcinoma of the thyroid?, Am J Surg Pathol, 1979, 3(1):31-38.
22. LLOYD R. V., ERICKSON L. A., CASEY M. B., LAM K. Y., LOHSE C. M., ASA S. L., CHAN J. K., DELELLIS R. A., HARACH H. R., KAKUDO K., LIVOLSI V. A., ROSAI J., SEBO T. J., SOBRINHO-SIMOES M., WENIG B. M., LAE M. E., Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma, Am J Surg Pathol, 2004, 28(10):1336-1340.
23. LIVOLSI V. A., Surgical pathology of the thyroid. In: BENNINGTON J. L. (ed), Major problems in pathology, vol. 22, W. B. Saunders Company, Philadelphia, 1990.
24. ROSAI J., CARCANGIU M. L., DELELLIS R. A., Tumors of the thyroid gland. In: Atlas of tumor pathology, Armed Forces Institute of Pathology, Washington DC, 1990.
25. ASIOLI S., BUSSOLATI G., Nuclear shape in thyroid lesions, as revealed by tagging of the nuclear membrane, Histopathology, 2008, in press.